Clinical Features of Pulmonary Tuberculosis Patients Performing Molecular Rapid Test at Jakarta Islamic Hospital Cempaka Putih

Fida Alia Shabrina; Rayhana Rayhana; Tri Wahyuni

doi:10.24853/mmj.6.1.59-67

Authors

Fida Alia Shabrina Universitas Muhammadiyah Jakarta
Rayhana Rayhana Fakultas Kedokteran dan Kesehatan, Universitas Muhammadiyah Jakarta
Tri Wahyuni Fakultas Kedokteran dan Kesehatan, Universitas Muhammadiyah Jakarta

DOI:

https://doi.org/10.24853/mmj.6.1.59-67

Keywords:

clinical feature, TCM, tuberculosis

Abstract

Background: Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. This germ has a dormant phase, which causes the healing process to take a long time, thereby increasing the risk of discontinuing drug consumption in TB patients. This has resulted in resistance to several types of anti-tuberculosis drugs, one of which is Rifampicin, a first-line drug in TB treatment. Rifampicin-resistant TB (RR-TB) requires rapid and precise diagnosis and treatment, namely the PCR method using the GeneXpert tool. Purposes: To find out the clinical features of pulmonary tuberculosis patients performing TCM GeneXpert at the Jakarta Islamic Hospital Cempaka Putih in January – June 2022. Methods: This study employs a descriptive observational method, which describes a clinical feature based on secondary data (medical records) from adult pulmonary TB patients undergoing TCM at RSIJ Cempaka Putih. Results: Among patients examined by Molecular Rapid Test, 64 individuals (59.3%) were MTB-detected, and among them, 12 individuals (18.8%) had rifampicin resistance. The highest positivity value from the results of MTB-detected was MTB-Medium Detected, namely 11 people (10.2%). The most common clinical symptom in pulmonary TB patients was cough with phlegm, which was 67 people (62%), and the comorbidity that most patients suffered was diabetes mellitus, which was 21 people (19.4%). Conclusions: The frequency distribution of the Molecular Rapid Test (MRT) results showed that 59.3% of the MTB-detected cases were rifampicin-resistant, with 18.8% of the total. Cough with phlegm is the most common clinical symptom experienced by TB patients, namely 62%.

References

Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Nomor HK.01.07/MENKES/755/2019 Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Jakarta; 2019.

Centers for Disease Control and Prevention. Basic TB Facts: Signs & Symptoms. 2022 [cited 2022 Oct 24]. Available from: https://www.cdc.gov/tb/topic/basics/ signsandsymptoms.htm

Persatuan Dokter Paru Indonesia. Tuberkulosis: Pedoman Diagnosis dan Penatalaksanaan di Indonesia. Jakarta; 2021.

Kementerian Kesehatan Republik Indonesia. Petunjuk Teknis Penatalaksaan Tuberkulosis Resistan Obat di Indonesia. Jakarta; 2020.

World Health Organization (WHO). Global Tuberculosis Report 2020. Geneva; 2020.

Kementerian Kesehatan Republik Indonesia. Petunjuk Teknis Pemeriksaan TB Menggunakan Tes Cepat Molekuler. Jakarta; 2017.

Centers for Disease Control and Prevention (CDC). A New Tool to Diagnose Tuberculosis: The Xpert MTB/RIF Assay. 2016 [cited 2023 Jan 15]. Available from: https://www.cdc.gov/tb/publications/factsheets/testing/xpert_mtb-rif.htm

Kementerian Kesehatan Republik Indonesia. RR/MDR TB Enrollment Rate. 2022 [cited 2022 Oct 24]. Available from: https://tbindonesia.or.id/pustaka-tbc/dashboard-tb/#tab-634ba7237cd46-7

Di Gennaro F, Vittozzi P, Gualano G, Musso M, Mosti S, Mencarini P, et al. Active pulmonary tuberculosis in elderly patients: a 2016–2019 retrospective analysis from an Italian Referral Hospital. Antibiotics. 2020;9(8):489.

Centers for Disease Control and Prevention (CDC). Diagnosing Latent TB Infection & TB Disease. 2016 [cited 2022 Oct 24]. Available from: https://www.cdc.gov/tb/ topic/testing/diagnosingltbi.htm

Centers for Disease Control and Prevention (CDC). Latent TB Infection and TB Disease. 2020 [cited 2022 Oct 24]. Available from: https://www.cdc.gov/tb/topic/basics/ tbinfectiondisease.htm

Caraux-Paz P, Diamantis S, de Wazières B, Gallien S. Tuberculosis in the Elderly. J Clin Med. 2021 Dec;10(24).

Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TPD of TE. Core Curriculum on Tuberculosis: What the Clinician Should Know. 2021.

Sunarmi S, Kurniawaty K. hubungan karakteristik pasien TB Paru dengan kejadian tuberkulosis. Jurnal’Aisyiyah Med. 2022;7(2).

Centers for Disease Control and Prevention (CDC). TB risk factors. 2016 [cited 2022 Oct 24]. Available from: https://www.cdc.gov/tb/topic/basics/risk.htm

Miller PB, Zalwango S, Galiwango R, Kakaire R, Sekandi J, Steinbaum L, et al. Association between tuberculosis in men and social network structure in Kampala, Uganda. BMC Infect Dis. 2021;21(1):1023.

Savitri AR, Muliani Y, Yuliana Y. Karakteristik penderita tuberkulosis paru dengan diabetes melitus di kabupaten badung tahun 2017-2018. E-Jurnal Med Udayana. 2021;10(1):60–4.

An Q, Song W, Liu J, Tao N, Liu Y, Zhang Q, et al. Primary drug-resistance pattern and trend in elderly tuberculosis patients in Shandong, China, from 2004 to 2019. Infect Drug Resist. 2020;4133–45.

Dewi A, Andrika P, Artana IB, Kunci K. Gambaran karakteristik pasien tuberculosis di poliklinik paru RSUP Sanglah Denpasar. J Med Udayana. 2020;9(6):9.

Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442–9.